Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An aggressive malignant smooth muscle neoplasm, arising from the retroperitoneum. It is characterized by a proliferation of neoplastic spindle cells.
Biomarker and diagnostic research for retroperitoneal leiomyosarcoma has been reported in the published literature.
No clinical trials have been registered for retroperitoneal leiomyosarcoma.
38 publications have been identified in PubMed for retroperitoneal leiomyosarcoma. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (21%), and Epidemiology / Natural History (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 19 | 50% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 1:00 PM UTC
Research summaries
8 |
21% |
Disease patterns and progression | 4 | 11% |
Other research | 2 | 5% |
Testing and diagnosis research | 2 | 5% |
Clinical study results | 2 | 5% |
New treatment approaches | 1 | 3% |
Huang K (2026). [PMID: 41786979](https://pubmed.ncbi.nlm.nih.gov/41786979/). *Sci Rep*. [Clinical Trial Publication]
Jaiswal S (2026). [PMID: 41939545](https://pubmed.ncbi.nlm.nih.gov/41939545/). *Cureus*. [Review / Meta-Analysis]
Choksi A (2026). [PMID: 41678049](https://pubmed.ncbi.nlm.nih.gov/41678049/). *Ann Surg Oncol*. [Case Report / Case Series]
Spasojevic M (2026). [PMID: 41797032](https://pubmed.ncbi.nlm.nih.gov/41797032/). *Eur J Surg Oncol*. [Epidemiology / Natural History]
Malik N (2026). [PMID: 41744854](https://pubmed.ncbi.nlm.nih.gov/41744854/). *Curr Oncol*. [Epidemiology / Natural History]
Jia N (2026). [PMID: 41716942](https://pubmed.ncbi.nlm.nih.gov/41716942/). *Oncol Rev*. [Review / Meta-Analysis]
Cui H (2025). [PMID: 40051557](https://pubmed.ncbi.nlm.nih.gov/40051557/). *J Hepatocell Carcinoma*. [Case Report / Case Series]
Hettler M (2025). [PMID: 40105939](https://pubmed.ncbi.nlm.nih.gov/40105939/). *Chirurgie (Heidelb)*. [Review / Meta-Analysis]
Song H (2025). [PMID: 40843294](https://pubmed.ncbi.nlm.nih.gov/40843294/). *Radiol Case Rep*. [Case Report / Case Series]
Eid K (2025). [PMID: 40988997](https://pubmed.ncbi.nlm.nih.gov/40988997/). *J Ophthalmic Vis Res*. [Case Report / Case Series]
AI-curated news mentioning retroperitoneal leiomyosarcoma
Updated Sep 10, 2026
A recent publication discusses the management strategies for soft tissue and visceral leiomyosarcomas, highlighting current treatment approaches and outcomes. This research contributes to the understanding of this rare cancer type.
A case study published in PubMed details metastatic leiomyosarcoma in an adult budgerigar, highlighting the disease's impact on bone and kidney. This research contributes to the understanding of leiomyosarcoma in avian species.
A case report highlights a rare collision tumor involving MMR deficient dedifferentiated endometrial carcinoma and synchronous uterine leiomyosarcoma. This study contributes to the understanding of these rare tumor types and their potential interactions.